| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Principal Accounting Officer and Vice President, Finance | Stock Option (Right to Buy) | 100,000 | 20 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | 20 Jan 2026 | 1 | $0 | 4 | Principal Accounting Officer and Vice President, Finance | 22 Jan 2026, 17:30 |
| TCRX | TScan Therapeutics, Inc. | 14 Aug 2025 | 0 | $0 | 3 | Principal Accounting Officer | 22 Aug 2025, 16:10 |
| TCRX | TScan Therapeutics, Inc. | 12 Jan 2024 | 1 | $0 | 4 | Vice President, Finance | 11 Feb 2025, 17:54 |
| TCRX | TScan Therapeutics, Inc. | 21 Jul 2023 | 1 | $0 | 4 | Chief Accounting Officer | 24 Jul 2023, 19:39 |
| TCRX | TScan Therapeutics, Inc. | 21 Jul 2023 | 0 | $0 | 3 | Chief Accounting Officer | 24 Jul 2023, 19:31 |